Position in CELU
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11
+$10 QoQ
Shares Held
21
+2000.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#36
of 39 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CELU Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,717,846,799 across 523 Biotechnology names. CELU ranks #509 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in CELU
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11 | 21 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1 | 1 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 | $6,210 | 3,000 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $196 | 100 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $86 | 50 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $104 | 50 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $148 | 50 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $1,095 | 350 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $46,285 | 8,850 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $12,672 | 51,306 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $17,795 | 80,165 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $55,689 | 104,490 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $35,407 | 57,113 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $91,619 | 71,025 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $230,867 | 99,944 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $260,687 | 76,673 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $434,471 | 49,882 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $256,136 | 50,027 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $361,079 | 51,000 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 GXGX | — | 11,395 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 GXGX | — | 20,521 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 GXGX | — | 16,660 | Shares | Defined | 2021-02-16 | |
| 2020-03-31 GXGX | — | 353 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||